Carmichael Hill & Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $312K | Sell |
2,713
-212
| -7% | -$24.4K | 0.11% | 133 |
|
2024
Q2 | $311K | Hold |
2,925
| – | – | 0.12% | 124 |
|
2024
Q1 | $283K | Hold |
2,925
| – | – | 0.11% | 136 |
|
2023
Q4 | $295K | Sell |
2,925
-103
| -3% | -$10.4K | 0.12% | 123 |
|
2023
Q3 | $308K | Hold |
3,028
| – | – | 0.14% | 112 |
|
2023
Q2 | $306K | Hold |
3,028
| – | – | 0.14% | 115 |
|
2023
Q1 | $279K | Hold |
3,028
| – | – | 0.13% | 120 |
|
2022
Q4 | $275K | Sell |
3,028
-50
| -2% | -$4.54K | 0.14% | 113 |
|
2022
Q3 | $234K | Hold |
3,078
| – | – | 0.13% | 123 |
|
2022
Q2 | $260K | Sell |
3,078
-205
| -6% | -$17.3K | 0.14% | 120 |
|
2022
Q1 | $288K | Sell |
3,283
-125
| -4% | -$11K | 0.13% | 125 |
|
2021
Q4 | $298K | Sell |
3,408
-400
| -11% | -$35K | 0.13% | 120 |
|
2021
Q3 | $311K | Hold |
3,808
| – | – | 0.15% | 110 |
|
2021
Q2 | $347K | Sell |
3,808
-100
| -3% | -$9.11K | 0.18% | 104 |
|
2021
Q1 | $334K | Hold |
3,908
| – | – | 0.18% | 103 |
|
2020
Q4 | $369K | Hold |
3,908
| – | – | 0.22% | 89 |
|
2020
Q3 | $340K | Hold |
3,908
| – | – | 0.23% | 84 |
|
2020
Q2 | $341K | Sell |
3,908
-350
| -8% | -$30.5K | 0.25% | 79 |
|
2020
Q1 | $351K | Hold |
4,258
| – | – | 0.31% | 69 |
|
2019
Q4 | $403K | Buy |
4,258
+150
| +4% | +$14.2K | 0.29% | 70 |
|
2019
Q3 | $357K | Buy |
4,108
+100
| +2% | +$8.69K | 0.35% | 75 |
|
2019
Q2 | $366K | Sell |
4,008
-465
| -10% | -$42.5K | 0.36% | 76 |
|
2019
Q1 | $385K | Sell |
4,473
-112
| -2% | -$9.64K | 0.4% | 69 |
|
2018
Q4 | $353K | Hold |
4,585
| – | – | 0.4% | 71 |
|
2018
Q3 | $354K | Sell |
4,585
-78
| -2% | -$6.02K | 0.34% | 76 |
|
2018
Q2 | $316K | Sell |
4,663
-446
| -9% | -$30.2K | 0.34% | 78 |
|
2018
Q1 | $370K | Sell |
5,109
-335
| -6% | -$24.3K | 0.4% | 70 |
|
2017
Q4 | $410K | Buy |
+5,444
| New | +$410K | 0.45% | 68 |
|